In a world where rare diseases often fly under the radar, one condition is now taking center stage with promising developments—Osteogenesis Imperfecta (OI), commonly known as brittle bone disease. The Osteogenesis Imperfecta Treatment Market is gaining attention as groundbreaking therapies and improved diagnostics are set to redefine the future for patients globally. A Fragile...